Skip to main content
SpringerLink
Log in

Épidémiologie, facteurs de risque, dépistage

  • Chapter
Le cancer du sein

Part of the book series: Oncologie pratique ((ONCOLPRAT))

  • 585 Accesses

Abstrait

Avec 42 000 nouveaux cas en France, le cancer du sein occupe le premier rang des cancers féminins. Dans la plupart des pays industrialisés, il constitue la première cause de mortalité par cancer chez les femmes, sauf aux États-Unis et en Grande-Bretagne où le cancer bronchique induit une mortalité plus élevée (1, 2). Ces statistiques en font un véritable problème de santé publique. Il touche de façon préférentielle les femmes de moins de 60 ans, avec un pic de fréquence observé vers ľâge de 50 ans (3). Un diagnostic précoce est, au côté des avancĘs thérapeutiques significatives récentes, un élément clef permettant ďaméliorer le pronostic.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Centers for Disease Control and Prevention. (1993) Smoking-attributable mortality and years of potential life lost — United States, 1990. Morbidity and Mortality Weekly Report 42 (33): 645–8

    Google Scholar 

  2. Wild S H, Fischbacher C M, Brock A et al. (2006) Mortality from all cancers and lung, colorectal, breast and prostate cancer by country of birth in England and Wales, 2001–2003. Brit J Cancer; 94: 1079–85

    Article  PubMed  CAS  Google Scholar 

  3. Anderson WF, Chu KC, Chang S et al. (2004) Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma. Cancer Epidemiol Biomarkers Prev, 13: 1128–35

    PubMed  Google Scholar 

  4. Althuis MD, Dozier JM, Anderson WF et al. (2005) Global trends in breast cancer incidence and mortality 1973–1997. Internat J Epidemiol; 34: 405–12

    Article  Google Scholar 

  5. Forbes JF. The control of breast cancer: The role of tamoxifen. Seminars in Oncol 1997; 24 (1) Suppl 1: S1-5–S1-19

    Google Scholar 

  6. Estève J. (2005) Qui? Combien? Tentative de description démographique de la population concernée. La lettre du Sénologue (29) (Suppl 1): 4–6

    Google Scholar 

  7. Yang L., Parkin DM, Feraly J et al. Estimates of cancer incidence in China for 2005 and projections for 2005. Cancer Epidemiol Biomarkers Prev 2005; 14 (1): 243–50

    PubMed  Google Scholar 

  8. Remontet I, Buemi A, Velten M et al. Évolution de ľincidence et de la mortalité par cancer en France de 1978 à 2000. Institut de Veille Sanitaire, avril 2003

    Google Scholar 

  9. Botha JL, Bray F, Sankila R et al. Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer 2003; 39: 1718–29

    Article  PubMed  CAS  Google Scholar 

  10. Trétarre B, Guizard AV, Fontaine D, et al. Cancer du sein chez la femme: incidence et mortalité, France 2000. BEH 2004; 44: 209–10

    Google Scholar 

  11. Estève J. (2005) Qui? Combien? Tentative de description démographique de la population concernée. La lettre du Sénologue; 29(Suppl 1): 4–6

    Google Scholar 

  12. Stanford JL, Greenberg RS (1989) Breast cancer incidence in young women by estrogen receptor status and race. Am J Publ Health; 79: 71–3

    CAS  Google Scholar 

  13. Smigal C, Jemal A, Ward E et al. (2006) Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin; 56: 168–83

    PubMed  Google Scholar 

  14. Ravdin PM et al. (2006) A sharp decrease in breast cancer incidence in United States in 2003. Proceedings Breast Cancer San Antonio symposium

    Google Scholar 

  15. Remontet L, Esteve J, Bouvier A M et al. (2003) Incidence et mortalité des cancers en France. Période 1978–2000. Rev Epidemiol Sante Publique; 51: 3–30

    PubMed  CAS  Google Scholar 

  16. Eisinger F, Bressac B, Castaigne D et al. (2004) Identificatione et prise en charge des prédispositions aux cancers du sein et de ľovaire (mise à jour 2004) Bull Cancer, 91: 219–37

    PubMed  Google Scholar 

  17. Antoniou A, Pharoah PD, Narod S et al. (2005) Average risks of breast cancer and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet; 72: 1117–30

    Article  Google Scholar 

  18. Collaborative Group on Hormonal Factors in Breast Cancer (1997) Breast Cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52705 women with breast cancer and 108411 women without breast cancer. Lancet; 350: 1047–59

    Article  Google Scholar 

  19. Hunter DJ, Spiegelman D, Adami HO et al. (1997) Non-dietary factors as risk factors for breast cancer, and as effect modifiers of the association of fat intake and risk of breast cancer. Cancer Causes Contre; 8: 49–56

    Article  CAS  Google Scholar 

  20. Tryggvadottir L, Olafsdottir Ej, Gudlaugsdottir S, et al. (2003) BRCA2 mutation carriers, reproductive factors and breast cancer risk. Breast Cancer Res; 5: R121–8

    Article  PubMed  CAS  Google Scholar 

  21. Liu Q, Wuu J, Lambe M et al. (2002) Transiet increase in breast cancer risk after giving birth: postpartum period with the highest risk (Sweden). Cancer Causes Control 2002; 13: 299–305

    Article  Google Scholar 

  22. Bruzzi P, Negri E, La Vecchia C. (1988) Short term increase in risk of breast cancer after full term pregnancy. Brit Med J; 297: 1096–8

    Article  PubMed  CAS  Google Scholar 

  23. Ewertz M, Duffy SW, Adami HO (1990) Age at first birth, parity and risk of breast cancer. A meta-analysis of 8 studies from the Nordic countries. Int J Cancer; 46: 597–603

    Article  PubMed  CAS  Google Scholar 

  24. Mac Mahon B, Cole P. (1970) Age at first birth and breast cancer risk. Bull WHO; 43: 209–21

    CAS  Google Scholar 

  25. Collaborative Group on Hormonal Factors in Breast Cancer. (2002) Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50 302 women with breast cancer and 96 973 women without the disease. Lancet; 360: 187–95

    Article  Google Scholar 

  26. Rosero-Bixby L, Oberle MW, Lee NC (1987) Reproductive history and breast cancer in a population of high fertility. Costa Rica. 1984–1985. Int J Cancer; 40: 747–54

    Article  PubMed  CAS  Google Scholar 

  27. Collaborative Group on Hormonal Factors in Breast Cancer Breast Cancer and hormonal contraceptives. Collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Lancet 1996; 347: 1713–27

    Article  Google Scholar 

  28. Sellers TA, Mink PJ, Cerphan JR et al. (1997) The role of hormone replacement therapy in the risk of breast cancer and total mortality in women with a family history of breast cancer. Ann Inter Med.; 127: 973–80

    CAS  Google Scholar 

  29. Writing Group for the Women’s Health Initiative Investigators (2002) Risk and benefits of oestrogen plus progestin in healthy post-menopausal women: principal results from the Women’s Health initiative randomized controlled trial: JAMA; 288: 321–33

    Article  Google Scholar 

  30. Collaborative Group on Hormonal Factors in Breast Cancer (2002) Alcohol, tobacco and breast cancer: collaborative reanalysis of individual data from 53 epidemiological studies, including 58515 women with breast cancer and 95067 women without the disease. Br J Cancer; 87: 1234–45

    Article  Google Scholar 

  31. Reynolds P, Hurley S, Goldberg D E et al. (2004) Active smoking, household passive smoking, and breast cancer: evidence from the California Teachers Study. J Natl Cancer Inst 2004; 96: 29–37

    CAS  Google Scholar 

  32. Tavani A, Pregnolato A, La Vecchia C et al. (1998) Coffee consumption and the risk of breast cancer. Eur J Cancer Prev.; 7: 77–82

    PubMed  CAS  Google Scholar 

  33. Missmer S A, Smith-Warner S A, Spiegelman D et al. (2002) Meat and dairy food consumption and breast cancer: a pooled analysis of cohort studies. Int J Epidemiol; 31: 48–85

    Article  Google Scholar 

  34. Baghurst PA & Rohan TE (1994) High-fiber diets and reduced risk of breast cancer. Int J Cancer; 56: 173–6

    Article  PubMed  CAS  Google Scholar 

  35. Barrett-Connor E, Friedlander NJ (1993) Dietary fat, calories, and the risk of breast cancer in postmenopausal women: a prospective population-based study J Am Coll Nutr; 12: 390–9

    PubMed  CAS  Google Scholar 

  36. Franceschi S, Faver A, Decarli A (1996) Intake of macronutrients and risk of breast cancer. Lancet; 347: 1351–6

    Article  PubMed  CAS  Google Scholar 

  37. Gandini S, Merzenich H, Robertson C et al. (2000) Meta-analysis of studies on breast cancer risk and diet. The role of fruit and vegetable consumption and the intake of associated micronutrients. Eur J Cancer; 36: 636–46

    Article  PubMed  CAS  Google Scholar 

  38. Terry P, Jain M, Miller AB et al. (2002) No association among total dietary fiber, fiber fractions, and risk of breast cancer, Cancer Epidemiol Biomarkers Prev; 11: 1507–8

    PubMed  Google Scholar 

  39. Ingram D, Sanders K, Kolybaba M, Lopez D (1997) Case-control study of phytooestrogens and breast cancer. Lancet; 350: 990–4

    Article  PubMed  CAS  Google Scholar 

  40. Albanes D (1987) Caloric intake, body weight and cancer: a review. Nutr Cancer; 9: 199–217

    PubMed  CAS  Google Scholar 

  41. London SJ, Colditz GA, Stampfer MJ (1989) Prospective study of relative height and risk of breast cancer. J. Am Med Assoc; 262: 2853–8

    Article  CAS  Google Scholar 

  42. Folsfom AR, Kaye SA, Prineas RJ et al. (1990) Increased incidence of carcinoma of the breast associated with abdominal adiposity in postmenopausal women. Am J Epidemiol; 131: 794–803

    Google Scholar 

  43. Lahmann PH, Hoffmann K, Allen N et al. (2004) Body size and breast cancer risk: finding from the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer; 111: 762–71

    Article  PubMed  CAS  Google Scholar 

  44. Hunter DL, Willett WC (1993) Diet, body size, and breast cancer. Epidemiol Rev; 15: 110–32

    PubMed  CAS  Google Scholar 

  45. Cleary MP, Maihle NJ (1997) The role of body mass index in the relative risk of developing premenaupausal versus postmenopausal breast cancer. Proc soc Exp Biol Med; 216: 28–43

    PubMed  CAS  Google Scholar 

  46. Friedenreich CM, Thune I, Brinton LA, Albanes D (1998) Epidemiologic issues related to the association between physical activity and breast cancer; Cancer; 83: 600–10

    Article  PubMed  CAS  Google Scholar 

  47. International Agency for Research on Cancer (2002) Weight control and physical activity. Lyon: IARC Press

    Google Scholar 

  48. Tokunaga M, Land CE, Tokuoka C (1994) Incidence of female breast cancer among atomic bomb survivors. Radiat Res; 138: 209–23

    Article  PubMed  CAS  Google Scholar 

  49. Miller AB, Howe GR, Sherman GJ et al. (1989) Mortality from breast cancer after irradiation during fluoroscopy examination in patients being treated for tuberculosis. N Engl J Med; 321: 1285–89

    PubMed  CAS  Google Scholar 

  50. Hancock S, Tucker M, Hoppe R (1993) Breast cancer after treatment of hodgkin’s disease. J Natl Cancer Inst; 85: 25–31

    Article  PubMed  CAS  Google Scholar 

  51. Coogan PF, Aschengrau A (1998) Exposure to power frequency magnetic fields and risk of breast cancer in the Upper Cape Cod Cancer Incidence Study. Arch Environ Health; 3: 359–67

    Article  Google Scholar 

  52. Darbre PD, Aljarrah A, Miller WR et al. (2004) Concentrations of parabens in human breast cancer. J Appl Toxicol; 24: 5–13

    Article  PubMed  CAS  Google Scholar 

  53. Mirick DK, Davis S, Thomas DB (2002) Antiperspirant use and the risk of breast cancer. J Natl Cancer Inst; 94: 1578–80

    PubMed  Google Scholar 

  54. Newman LA, Hayes DF (2006) Evidence based management of breast cancer. In Oncology An Evidence-Based Approach. Ed Springer

    Google Scholar 

  55. Pivot X et al. (2006) Cancer screening tests in France: first results of the EDIFICE study. ESMO Istanbul; Abst 1095

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service ďoncologie médicale, Hôpital Avicenne, 125, route de Stalingrad, 93000, Bobigny Cedex

    P. Amsalhem, R. Etessami & J. -F. Morère

Authors
  1. P. Amsalhem
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Etessami
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. -F. Morère
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag France

About this chapter

Cite this chapter

Amsalhem, P., Etessami, R., Morère, J.F. (2007). Épidémiologie, facteurs de risque, dépistage. In: Le cancer du sein. Oncologie pratique. Springer, Paris. https://doi.org/10.1007/978-2-287-36073-2_1

Download citation

  • DOI: https://doi.org/10.1007/978-2-287-36073-2_1

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-36071-8

  • Online ISBN: 978-2-287-36073-2

Publish with us

Policies and ethics

Search

Navigation